You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 122 No. 4, April 1987 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS READ BEFORE THE 67TH ANNUAL MEETING OF THE NEW ENGLAND SURGICAL SOCIETY, DIXVILLE NOTCH, NH, SEPTEMBER 26-28, 1986
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Cystic Neoplasms of the Pancreas

Stephen G. ReMine, MD; Daniel Frey, MD; Ricardo L. Rossi, MD; J. Lawrence Munson, MD; John W. Braasch, MD

Arch Surg. 1987;122(4):443-446.


Abstract

• From 1963 to 1983, 26 patients with cystic neoplasms of the pancreas were treated at the Lahey Clinic, Burlington, Mass. Cystadenoma (15 patients) was more common than cystadenocarcinoma (11 patients). Preoperative symptoms, such as abdominal pain, were present for as long as 18 years before diagnosis. The mean size of cysts was 7 cm. Distal pancreatectomy, the most common operation, was performed in ten patients. Eight of the 11 patients with cystadenocarcinoma had metastatic disease at the time of surgical exploration. There was one postoperative death (3.8%). Patients with cystadenocarcinoma had an adjusted median survival time after operation of 6.0 months. The long prodrome in many of the cancer patients suggests that benign cystadenomas, particularly of the mucinous type, may undergo malignant degeneration. Benign cystadenoma seems unlikely to recur after adequate resection. Whenever possible, complete excision of cystadenoma and cystadenocarcinoma is the procedure of choice.

(Arch Surg 1987;122:443-446)



Author Affiliations

From the Department of Surgery, Lahey Clinic Medical Center, Burlington, Mass. Dr Frey is now with the Department of Surgery, Louisiana State University Hospital, New Orleans.


Footnotes

Accepted for publication Jan 28, 1987.

Read before the 67th Annual Meeting of the New England Surgical Society, Dixville Notch, NH, Sept 27, 1986.

Reprint requests to Department of Surgery, Lahey Clinic Medical Center, 41 Mall Rd, Burlington, MA 01805 (Dr ReMine).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Incidental Pancreatic Cysts: Clinicopathologic Characteristics and Comparison With Symptomatic Patients
Castillo et al.
Arch Surg 2003;138:427-434.
ABSTRACT | FULL TEXT  

CT of Primary Cystic Pancreatic Neoplasms: Can CT be Used for Patient Triage and Treatment?
Curry et al.
Am. J. Roentgenol. 2000;175:99-103.
ABSTRACT | FULL TEXT  

Intraductal Papillary Mucinous Tumors of the Pancreas Comprise 2 Clinical Subtypes: Differences in Clinical Characteristics and Surgical Management
Kobari et al.
Arch Surg 1999;134:1131-1136.
ABSTRACT | FULL TEXT  

Intraoperative Pancreatoscopy With the Ultrathin Pancreatoscope for Mucin-Producing Tumors of the Pancreas
Kaneko et al.
Arch Surg 1998;133:263-267.
ABSTRACT | FULL TEXT  

Cystic Neoplasms of the Pancreas: A Clinicopathologic Study, Including DNA Flow Cytometry
Brenin et al.
Arch Surg 1995;130:1048-1054.
ABSTRACT  

Nonductal Tumors of the Pancreas: The Importance of Laparotomy
De Jong et al.
Arch Surg 1993;128:730-736.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.